MannKind Corporation (MNKD) Stock Ratings


View Stock Quote:

Login Required

You must login before you can rate this stock.

Login Now

Community Rating:


Bullish

100% of 2 ratings
View All-Time Ratings

Do the wall street analysts agree?

Consensus Recommendation:

View detailed analyst research

Other Member Ratings

View Most Rated Stocks

Member Call Date Rated Timeframe Start Price End Price Stock Gain/Loss Score Status
EXCLUSIVELYYOURS.INFO EXCLUSIVELYYOURS.INFO 03/08/2018 3 months $2.77 $1.94 -29.96% -29 Ended
Comments:
findingomega findingomega 03/05/2018 1 Year $2.88 $1.92 -33.22% -33 Active
Comments:
Netteligent Netteligent 02/15/2018 1 month $3.24 $2.65 -18.08% 18 Ended
Comments:
OktayLacin OktayLacin 12/13/2017 3 months $3.02 $2.61 -13.58% -13 Ended
Comments:
anzhelagv anzhelagv 10/31/2017 3 months $3.29 $2.79 -15.2% 15 Ended
Comments:
KoteMumladze KoteMumladze 10/30/2017 3 months $3.43 $2.79 -18.66% -18 Ended
Comments:
alphaseatraveller alphaseatraveller 10/26/2017 1 day $3.32 $3.37 +1.66% -1 Ended
Comments:
mjs0083151 mjs0083151 10/25/2017 1 week $3.47 $3.29 -5.05% 5 Ended
Comments:
RashadulKarimChowdhury RashadulKarimChowdhury 10/21/2017 1 week $4.11 $3.37 -18% 18 Ended
Comments:
matrix_man matrix_man 10/18/2017 3 months $4.31 $2.41 -44.08% -44 Ended
Comments:
bluescorpion21 bluescorpion21 10/16/2017 1 week $5.28 $4.11 -22.16% -22 Ended
Comments:
kagami kagami 10/06/2017 1 week $4.96 $5.47 +10.28% 10 Ended
Comments: high levels of implied volatility, high open interest in $5 call options expiring in a couple days
Kareim M. Abbouda Kareim M. Abbouda 09/28/2017 1 Year $2.22 $1.92 -13.51% -13 Active
Comments: Lowest point | Entry Point | CALL LEAP
AlusineAllieu AlusineAllieu 09/28/2017 3 months $2.22 $2.34 +5.41% 5 Ended
Comments:
JoiMarquezP JoiMarquezP 09/11/2017 3 months $2.04 $3.17 +55.39% 55 Ended
Comments:
joepeeer joepeeer 09/01/2017 3 months $2.07 -7.25% 0 Ended
Comments: they good
aj1203yan aj1203yan 08/31/2017 3 months $2.07 -7.25% 0 Ended
Comments: Industry growing or poised for growth
pawankumar pawankumar 07/20/2017 3 months $1.37 $4.75 +247.99% 247 Ended
Comments: Our focus is patients, Our passion is innovation® MannKind Corporation develops patient-focused dr
AndersH97 AndersH97 07/14/2017 1 Year $1.31 $1.70 +29.77% 29 Ended
Comments: Looking good for long term Investing
LB007 LB007 12/21/2016 1 Year $0.71 $2.28 +221.08% 221 Ended
Comments: Going to be HUGE!
Displaying 1-20 of 73
<< first < previous 1 2 3 4 last >>

Neither NASDAQ, Inc. nor any of its affiliates (collectively "NASDAQ") makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Investment related advice and comments are solely those of the individuals who publish them and do not in any way represent the opinions of NASDAQ. Investors should undertake their own due diligence and carefully evaluate companies before investing.